Close

BioCryst Pharma (BCRX) Rally Overdone, Says Analyst

April 8, 2013 2:49 PM EDT Send to a Friend
Shares of BioCryst Pharma (Nasdaq: BCRX) climbed Monday morning. The move is tied to reports China was expediting approval of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login